Andrew Cooper
Stock Analyst at Raymond James
(1.04)
# 2100
Out of 5,358 analysts
167
Total ratings
45.10%
Success rate
-2.27%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HAE Haemonetics | Reiterates: Strong Buy | 115 105 | 70.5 | 48.94% | 9 | May 9, 2025 | |
MYGN Myriad Genetics | Reiterates: Outperform | 19 10 | 5.1 | 96.08% | 5 | May 7, 2025 | |
FLGT Fulgent Genetics | Reiterates: Outperform | 24 25 | 21.43 | 16.66% | 2 | May 5, 2025 | |
HOLX Hologic | Reiterates: Outperform | 90 71 | 64.34 | 10.35% | 12 | May 2, 2025 | |
RVTY Revvity | Reiterates: Outperform | 145 120 | 91.99 | 30.45% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 145 150 | 121.24 | 23.72% | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 39 59 | 48.05 | 22.79% | 3 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 26 24 | 13.08 | 83.49% | 14 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 650 667 | 401.77 | 66.02% | 6 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | 68 85 | 163.78 | -48.1% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Outperform | 100 76 | 29.52 | 157.45% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1 1 | n/a | n/a | 10 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 7 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Jun 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 39 | n/a | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 145 225 | n/a | n/a | 4 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Strong Buy | 20 | n/a | n/a | 1 | Mar 18, 2020 |